• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我应该如何治疗有亚临床心房颤动和心房高频事件的患者?当前的证据和临床重要性。

How should I treat patients with subclinical atrial fibrillation and atrial high-rate episodes? Current evidence and clinical importance.

机构信息

University Hospital St Josef-Hospital Bochum, Cardiology and Rhythmology, Ruhr University Bochum, Gudrunstraße 56, 44791, Bochum, Germany.

出版信息

Clin Res Cardiol. 2022 Sep;111(9):994-1009. doi: 10.1007/s00392-022-02000-7. Epub 2022 Mar 15.

DOI:10.1007/s00392-022-02000-7
PMID:35292844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9424173/
Abstract

Long-term and continuous ECG monitoring using cardiac implantable electronic devices and insertable cardiac monitors has improved the capability of detecting subclinical atrial fibrillation (AF) and atrial high-rate episodes. Previous studies demonstrated a high prevalence (more than 20%) in patients with cardiac implantable electronic devices or insertable cardiac monitors. Subclinical AF and atrial high-rate episodes are often suspected as the cause of prior or potential future ischemic stroke. However, the clinical significance is still uncertain, and the evidence is limited. This review aims to present and discuss the current evidence on the clinical impact of subclinical AF and atrial high-rate episodes. It focuses particularly on the association between the duration of the episodes and major clinical outcomes like thromboembolic events. As subclinical AF and atrial high-rate episodes are presumed to be associated with ischemic strokes, detection will be particularly important in patients with cryptogenic stroke and in high-risk patients for thromboembolism. In this context, it is also interesting whether there is a temporal relationship between the detection of subclinical AF and atrial high-rate episodes and the occurrence of thromboembolic events. In addition, the review will examine the question whether there is a need for a therapy with oral anticoagulation.

摘要

使用心脏植入式电子设备和可植入心脏监测器进行长期和连续的心电图监测提高了检测亚临床心房颤动(AF)和心房高心率事件的能力。先前的研究表明,在心脏植入式电子设备或可植入心脏监测器的患者中,其患病率较高(超过 20%)。亚临床 AF 和心房高心率事件常被怀疑为先前或潜在未来缺血性卒中的原因。然而,其临床意义仍不确定,证据有限。本综述旨在介绍和讨论亚临床 AF 和心房高心率事件的临床影响的现有证据。它特别关注事件持续时间与主要临床结局(如血栓栓塞事件)之间的关联。由于亚临床 AF 和心房高心率事件被认为与缺血性卒中有关联,因此在隐源性卒中和血栓栓塞高风险患者中,检测将尤为重要。在这种情况下,检测亚临床 AF 和心房高心率事件与血栓栓塞事件发生之间是否存在时间关系也是一个有趣的问题。此外,该综述将探讨是否需要进行口服抗凝治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b875/9424173/94850e4e8d65/392_2022_2000_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b875/9424173/b5634110029f/392_2022_2000_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b875/9424173/8fdc0f6ab1e5/392_2022_2000_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b875/9424173/94850e4e8d65/392_2022_2000_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b875/9424173/b5634110029f/392_2022_2000_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b875/9424173/8fdc0f6ab1e5/392_2022_2000_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b875/9424173/94850e4e8d65/392_2022_2000_Fig3_HTML.jpg

相似文献

1
How should I treat patients with subclinical atrial fibrillation and atrial high-rate episodes? Current evidence and clinical importance.我应该如何治疗有亚临床心房颤动和心房高频事件的患者?当前的证据和临床重要性。
Clin Res Cardiol. 2022 Sep;111(9):994-1009. doi: 10.1007/s00392-022-02000-7. Epub 2022 Mar 15.
2
Subclinical atrial fibrillation and stroke: insights from continuous monitoring by implanted cardiac electronic devices.亚临床房颤与卒中:植入式心脏电子设备连续监测的见解
Europace. 2015 Oct;17 Suppl 2:ii40-6. doi: 10.1093/europace/euv235.
3
Detection of Subclinical Atrial Fibrillation in High-Risk Patients Using an Insertable Cardiac Monitor.使用可植入式心脏监测仪检测高危患者的无症状性心房颤动。
JACC Clin Electrophysiol. 2017 Dec 26;3(13):1557-1564. doi: 10.1016/j.jacep.2017.06.020. Epub 2017 Nov 6.
4
Silent atrial fibrillation as a stroke risk factor and anticoagulation indication.无症状性心房颤动作为卒中的危险因素和抗凝治疗适应证。
Can J Cardiol. 2013 Jul;29(7 Suppl):S14-23. doi: 10.1016/j.cjca.2013.03.023.
5
Use of Anticoagulation for Thromboembolic Prophylaxis in Patients With Atrial High-Rate Episodes on Device Monitoring: A Narrative Review.使用抗凝药物预防设备监测下伴有快速心房活动的患者发生血栓栓塞事件:一项叙述性综述。
Am J Cardiol. 2024 Jan 15;211:183-190. doi: 10.1016/j.amjcard.2023.11.009. Epub 2023 Nov 7.
6
Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study.双腔起搏器和植入式心律转复除颤器指导下基于连续房颤负荷监测的间断抗凝治疗:来自非持续房颤个体化抗凝治疗(TACTIC-AF)试验的研究结果。
Heart Rhythm. 2018 Nov;15(11):1601-1607. doi: 10.1016/j.hrthm.2018.06.027. Epub 2018 Jul 6.
7
Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices.心脏植入式电子设备患者中与心房高频率发作相关的无症状性缺血性脑损伤。
Europace. 2015 Mar;17(3):364-9. doi: 10.1093/europace/euu267. Epub 2014 Oct 21.
8
Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future.亚临床心房颤动与卒中风险:过去、现在与未来。
Medicina (Kaunas). 2019 Sep 20;55(10):611. doi: 10.3390/medicina55100611.
9
Atrial High-Rate Episodes and Subclinical Atrial Fibrillation: State of the Art and Clinical Questions with Complex Solutions.房性快速心律失常发作与亚临床房颤:最新进展及具有复杂解决方案的临床问题
Rev Cardiovasc Med. 2024 Aug 22;25(8):305. doi: 10.31083/j.rcm2508305. eCollection 2024 Aug.
10
Long-term monitoring to detect atrial fibrillation with the indwelling implantable cardiac monitors.使用植入式心脏监测器进行长期监测以检测心房颤动。
Int J Stroke. 2018 Dec;13(9):893-904. doi: 10.1177/1747493018790023. Epub 2018 Aug 9.

引用本文的文献

1
Short-duration atrial fibrillation in ischemic stroke: high risk despite subclinical burden-a prospective cohort study.缺血性卒中患者的短期房颤:尽管亚临床负担较轻,但风险仍高——一项前瞻性队列研究
BMC Cardiovasc Disord. 2025 Aug 20;25(1):616. doi: 10.1186/s12872-025-05080-1.
2
An Evaluation of Neuron-Specific Enolase as a Biomarker of Neurological Impact in Pacemaker-Implanted Patients with Atrial High-Rate Episodes: An Observational Study from Turkey.评估神经元特异性烯醇化酶作为起搏器植入后出现心房高速率发作患者神经学影响生物标志物的研究:一项来自土耳其的观察性研究。
Medicina (Kaunas). 2025 Feb 12;61(2):324. doi: 10.3390/medicina61020324.
3

本文引用的文献

1
Atrial fibrillation detection using ambulatory smartwatch photoplethysmography and validation with simultaneous holter recording.使用可穿戴智能手表光电容积脉搏波描记法进行心房颤动检测,并与同时进行的 Holter 记录进行验证。
Am Heart J. 2022 May;247:55-62. doi: 10.1016/j.ahj.2022.02.002. Epub 2022 Feb 5.
2
Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement.心房颤动筛查:美国预防服务工作组推荐声明。
JAMA. 2022 Jan 25;327(4):360-367. doi: 10.1001/jama.2021.23732.
3
Atrial High-Rate Episode Duration Thresholds and Thromboembolic Risk: A Systematic Review and Meta-Analysis.
Continuous atrial fibrillation monitoring using a wearable smartwatch: Using long-term Holter as reference.
使用可穿戴智能手表进行持续性房颤监测:以长期动态心电图为参照
Digit Health. 2025 Jan 23;11:20552076251314105. doi: 10.1177/20552076251314105. eCollection 2025 Jan-Dec.
4
Pacemaker-induced atrial fibrillation reconsidered-associations with different pacing sites and prevention approaches.重新审视起搏器诱发的心房颤动——与不同起搏部位的关联及预防方法
Front Cardiovasc Med. 2024 Jun 18;11:1412283. doi: 10.3389/fcvm.2024.1412283. eCollection 2024.
5
Predictors of atrial fibrillation after embolic stroke of undetermined source in patients with implantable loop recorders.植入式环路记录器患者不明来源栓塞性卒中后心房颤动的预测因素。
Neurol Sci. 2024 Oct;45(10):4903-4912. doi: 10.1007/s10072-024-07548-y. Epub 2024 Apr 25.
6
Left Atrial Cardiomyopathy - A Challenging Diagnosis.左心房心肌病——一项具有挑战性的诊断。
Front Cardiovasc Med. 2022 Jun 30;9:942385. doi: 10.3389/fcvm.2022.942385. eCollection 2022.
心房高频事件持续时间阈值与血栓栓塞风险:系统评价和荟萃分析。
J Am Heart Assoc. 2021 Nov 16;10(22):e022487. doi: 10.1161/JAHA.121.022487. Epub 2021 Nov 10.
4
Atrial high-rate episodes predict major adverse cardio/cerebrovascular events in patients with cardiac implantable electrical devices.心房高频事件可预测植入心脏电子设备患者的主要不良心脑血管事件。
Sci Rep. 2021 Sep 23;11(1):18992. doi: 10.1038/s41598-021-98258-4.
5
Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial.植入式循环记录仪检测心房颤动以预防卒中(LOOP研究):一项随机对照试验
Lancet. 2021 Oct 23;398(10310):1507-1516. doi: 10.1016/S0140-6736(21)01698-6. Epub 2021 Aug 29.
6
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial.系统筛查心房颤动(STROKESTOP)的临床结局:一项多中心、平行组、非盲、随机对照试验。
Lancet. 2021 Oct 23;398(10310):1498-1506. doi: 10.1016/S0140-6736(21)01637-8. Epub 2021 Aug 29.
7
Characteristics of patients with atrial high rate episodes detected by implanted defibrillator and resynchronization devices.植入式除颤器和再同步装置检测到的心房高心率事件患者的特征。
Europace. 2022 Mar 2;24(3):375-383. doi: 10.1093/europace/euab186.
8
Detection of subclinical atrial fibrillation after cryptogenic stroke using implantable cardiac monitors.使用植入式心脏监测器检测隐源性卒中后的无症状性心房颤动。
Eur J Intern Med. 2021 Oct;92:86-93. doi: 10.1016/j.ejim.2021.06.022. Epub 2021 Jul 8.
9
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis.器械检测到的心房高心率事件与卒中/血栓栓塞和心房颤动发生率的风险:系统评价和荟萃分析。
Eur J Intern Med. 2021 Oct;92:100-106. doi: 10.1016/j.ejim.2021.05.038. Epub 2021 Jun 19.
10
The optimal cutoff of atrial high-rate episodes for neurological events in patients with dual chamber permanent pacemakers.双腔永久起搏器患者心房高频事件与神经事件的最佳切点。
Clin Cardiol. 2021 Jun;44(6):871-879. doi: 10.1002/clc.23626. Epub 2021 May 18.